1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Asthma Therapeutics Market
2.2. Global Asthma Therapeutics Market, By Drug Class, 2023 (US$ Million)
2.3. Global Asthma Therapeutics Market, By Product, 2023 (US$ Million)
2.4. Global Asthma Therapeutics Market, By Route, 2023 (US$ Million)
2.5. Global Asthma Therapeutics Market, By Geography, 2023 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2023

3. Asthma Therapeutics Market: Competitive Analysis
3.1. Market Positioning of Key Asthma Therapeutics Market Vendors
3.2. Strategies Adopted by Asthma Therapeutics Market Vendors
3.3. Key Industry Strategies
4. Asthma Therapeutics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Asthma Therapeutics Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Asthma Therapeutics Market: By Drug Class, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Anti-inflammatory Drugs
5.3.2. Bronchodilators
5.3.3. Combination therapy

6. Asthma Therapeutics Market: By Product, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Dry Powder Inhalers
6.3.2. Metered Dose Inhalers
6.3.3. Mist Inhalers
6.3.4. Nebulizer

7. Asthma Therapeutics Market: By Route, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. Inhalation
7.3.2. Oral
7.3.3. Parenteral


8. North America Asthma Therapeutics Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Asthma Therapeutics Market: By Drug Class, 2022-2032, USD (Million)
8.3. Asthma Therapeutics Market: By Product, 2022-2032, USD (Million)
8.4. Asthma Therapeutics Market: By Route, 2022-2032, USD (Million)
8.5.Asthma Therapeutics Market: By Region, 2022-2032, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Asthma Therapeutics Market: By Drug Class, 2022-2032, USD (Million)
8.5.1.1.2. Asthma Therapeutics Market: By Product, 2022-2032, USD (Million)
8.5.1.1.3. Asthma Therapeutics Market: By Route, 2022-2032, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Asthma Therapeutics Market: By Drug Class, 2022-2032, USD (Million)
8.5.1.2.2. Asthma Therapeutics Market: By Product, 2022-2032, USD (Million)
8.5.1.2.3. Asthma Therapeutics Market: By Route, 2022-2032, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Asthma Therapeutics Market: By Drug Class, 2022-2032, USD (Million)
8.5.1.3.2. Asthma Therapeutics Market: By Product, 2022-2032, USD (Million)
8.5.1.3.3. Asthma Therapeutics Market: By Route, 2022-2032, USD (Million)

9. UK and European Union Asthma Therapeutics Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Asthma Therapeutics Market: By Drug Class, 2022-2032, USD (Million)
9.3. Asthma Therapeutics Market: By Product, 2022-2032, USD (Million)
9.4. Asthma Therapeutics Market: By Route, 2022-2032, USD (Million)
9.5.Asthma Therapeutics Market: By Region, 2022-2032, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Asthma Therapeutics Market: By Drug Class, 2022-2032, USD (Million)
9.5.1.1.2. Asthma Therapeutics Market: By Product, 2022-2032, USD (Million)
9.5.1.1.3. Asthma Therapeutics Market: By Route, 2022-2032, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Asthma Therapeutics Market: By Drug Class, 2022-2032, USD (Million)
9.5.1.2.2. Asthma Therapeutics Market: By Product, 2022-2032, USD (Million)
9.5.1.2.3. Asthma Therapeutics Market: By Route, 2022-2032, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Asthma Therapeutics Market: By Drug Class, 2022-2032, USD (Million)
9.5.1.3.2. Asthma Therapeutics Market: By Product, 2022-2032, USD (Million)
9.5.1.3.3. Asthma Therapeutics Market: By Route, 2022-2032, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Asthma Therapeutics Market: By Drug Class, 2022-2032, USD (Million)
9.5.1.4.2. Asthma Therapeutics Market: By Product, 2022-2032, USD (Million)
9.5.1.4.3. Asthma Therapeutics Market: By Route, 2022-2032, USD (Million)
9.5.1.5. France
9.5.1.5.1. Asthma Therapeutics Market: By Drug Class, 2022-2032, USD (Million)
9.5.1.5.2. Asthma Therapeutics Market: By Product, 2022-2032, USD (Million)
9.5.1.5.3. Asthma Therapeutics Market: By Route, 2022-2032, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Asthma Therapeutics Market: By Drug Class, 2022-2032, USD (Million)
9.5.1.6.2. Asthma Therapeutics Market: By Product, 2022-2032, USD (Million)
9.5.1.6.3. Asthma Therapeutics Market: By Route, 2022-2032, USD (Million)

10. Asia Pacific Asthma Therapeutics Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Asthma Therapeutics Market: By Drug Class, 2022-2032, USD (Million)
10.3. Asthma Therapeutics Market: By Product, 2022-2032, USD (Million)
10.4. Asthma Therapeutics Market: By Route, 2022-2032, USD (Million)
10.5.Asthma Therapeutics Market: By Region, 2022-2032, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Asthma Therapeutics Market: By Drug Class, 2022-2032, USD (Million)
10.5.1.1.2. Asthma Therapeutics Market: By Product, 2022-2032, USD (Million)
10.5.1.1.3. Asthma Therapeutics Market: By Route, 2022-2032, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Asthma Therapeutics Market: By Drug Class, 2022-2032, USD (Million)
10.5.1.2.2. Asthma Therapeutics Market: By Product, 2022-2032, USD (Million)
10.5.1.2.3. Asthma Therapeutics Market: By Route, 2022-2032, USD (Million)
10.5.1.3. India
10.5.1.3.1. Asthma Therapeutics Market: By Drug Class, 2022-2032, USD (Million)
10.5.1.3.2. Asthma Therapeutics Market: By Product, 2022-2032, USD (Million)
10.5.1.3.3. Asthma Therapeutics Market: By Route, 2022-2032, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Asthma Therapeutics Market: By Drug Class, 2022-2032, USD (Million)
10.5.1.4.2. Asthma Therapeutics Market: By Product, 2022-2032, USD (Million)
10.5.1.4.3. Asthma Therapeutics Market: By Route, 2022-2032, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Asthma Therapeutics Market: By Drug Class, 2022-2032, USD (Million)
10.5.1.5.2. Asthma Therapeutics Market: By Product, 2022-2032, USD (Million)
10.5.1.5.3. Asthma Therapeutics Market: By Route, 2022-2032, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Asthma Therapeutics Market: By Drug Class, 2022-2032, USD (Million)
10.5.1.6.2. Asthma Therapeutics Market: By Product, 2022-2032, USD (Million)
10.5.1.6.3. Asthma Therapeutics Market: By Route, 2022-2032, USD (Million)

11. Latin America Asthma Therapeutics Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Asthma Therapeutics Market: By Drug Class, 2022-2032, USD (Million)
11.3. Asthma Therapeutics Market: By Product, 2022-2032, USD (Million)
11.4. Asthma Therapeutics Market: By Route, 2022-2032, USD (Million)
11.5.Asthma Therapeutics Market: By Region, 2022-2032, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Asthma Therapeutics Market: By Drug Class, 2022-2032, USD (Million)
11.5.1.1.2. Asthma Therapeutics Market: By Product, 2022-2032, USD (Million)
11.5.1.1.3. Asthma Therapeutics Market: By Route, 2022-2032, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Asthma Therapeutics Market: By Drug Class, 2022-2032, USD (Million)
11.5.1.2.2. Asthma Therapeutics Market: By Product, 2022-2032, USD (Million)
11.5.1.2.3. Asthma Therapeutics Market: By Route, 2022-2032, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Asthma Therapeutics Market: By Drug Class, 2022-2032, USD (Million)
11.5.1.3.2. Asthma Therapeutics Market: By Product, 2022-2032, USD (Million)
11.5.1.3.3. Asthma Therapeutics Market: By Route, 2022-2032, USD (Million)

12. Middle East and Africa Asthma Therapeutics Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Asthma Therapeutics Market: By Drug Class, 2022-2032, USD (Million)
12.3. Asthma Therapeutics Market: By Product, 2022-2032, USD (Million)
12.4. Asthma Therapeutics Market: By Route, 2022-2032, USD (Million)
12.5.Asthma Therapeutics Market: By Region, 2022-2032, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Asthma Therapeutics Market: By Drug Class, 2022-2032, USD (Million)
12.5.1.1.2. Asthma Therapeutics Market: By Product, 2022-2032, USD (Million)
12.5.1.1.3. Asthma Therapeutics Market: By Route, 2022-2032, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Asthma Therapeutics Market: By Drug Class, 2022-2032, USD (Million)
12.5.1.2.2. Asthma Therapeutics Market: By Product, 2022-2032, USD (Million)
12.5.1.2.3. Asthma Therapeutics Market: By Route, 2022-2032, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Asthma Therapeutics Market: By Drug Class, 2022-2032, USD (Million)
12.5.1.3.2. Asthma Therapeutics Market: By Product, 2022-2032, USD (Million)
12.5.1.3.3. Asthma Therapeutics Market: By Route, 2022-2032, USD (Million)

13. Company Profile
13.1. Abbott Laboratories
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. AstraZeneca
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. Becton, Dickinson and Company
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. Boehringer Ingelheim GmbH
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. Chiesi Farmaceutici
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. F. Hoffmann-La Roche
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. GlaxoSmithKline Plc.
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. Merck& Co., Inc.
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. Pfizer
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
13.10. Philips Healthcare
13.10.1. Company Overview
13.10.2. Financial Performance
13.10.3. Product Portfolio
13.10.4. Strategic Initiatives
13.11. Sanofi-Aventis SA
13.11.1. Company Overview
13.11.2. Financial Performance
13.11.3. Product Portfolio
13.11.4. Strategic Initiatives
13.12. Sunovion Pharmaceuticals, Inc.
13.12.1. Company Overview
13.12.2. Financial Performance
13.12.3. Product Portfolio
13.12.4. Strategic Initiatives
13.13. Teva Pharmaceutical Industries Ltd.
13.13.1. Company Overview
13.13.2. Financial Performance
13.13.3. Product Portfolio
13.13.4. Strategic Initiatives
13.14. Others
13.14.1. Company Overview
13.14.2. Financial Performance
13.14.3. Product Portfolio
13.14.4. Strategic Initiatives